http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4908376-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79751aeaa9923745648e5ae7d9c35782 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate | 1987-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1990-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_050f2c04f8a28f1bb8ec66135d9e6e9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda8d81880151b176dd5db5481ef4770 |
| publicationDate | 1990-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4908376-A |
| titleOfInvention | 2,3-dihydro-2-(4,5-dihydroimidazol-2-yl)-indoles in composition form for reducing intraocular pressure |
| abstract | Compounds of the formula ##STR1## wherein each R is hydrogen or one R is hydrogen and the other is lower alkyl, R 1 is hydrogen, lower alkyl, aryl, aralkyl or lower carboalkoxy, R 2 is hydrogen or lower alkyl, and the ring A is unsubstituted or substituted by lower alkyl, lower alkoxy, halo or trifluoromethyl, and pharmaceutically acceptable salts thereof, their preparation, pharmaceutical compositions and the uses thereof, such as α 2 -adrenergic blocking agents, e.g. antidepressants, cognition enhancers and appetite suppressants, and as intraocular pressure reducing agents are disclosed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007054453-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5385919-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007054453-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007112012-A1 |
| priorityDate | 1985-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.